Skip to main content
SpringerLink
Log in

Pediatrics

  • Chapter
  • First Online:
Practical Guide to Dermatology

  • 1266 Accesses

Abstract

Pediatric dermatology is a broad field. We will discuss atopic dermatitis , hemangiomas, molluscum contagiosum , morphea , neonatal specific rashes and diaper rashes . We have brief pediatric pearls for alopecia areata , psoriasis , tinea and scabies ; further information can be found in the corresponding adult section.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aronson PL, Shah SS, Mohamad Z, Yan AC. Topical corticosteroids and hospital length of stay in children with eczema herpeticum. Pediatr Dermatol. 2013;30(2):215–21.

    PubMed  Google Scholar 

  2. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–32.

    Google Scholar 

  3. Thomas KS, Armstrong S, Avery A, Po AL, O’Neill C, Young S, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ (Clin Res ed). 2002;324(7340):768.

    CAS  Google Scholar 

  4. Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011;164(2):415–28.

    CAS  PubMed  Google Scholar 

  5. Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol. 2002;147(3):528–37.

    CAS  PubMed  Google Scholar 

  6. Glazenburg EJ, Wolkerstorfer A, Gerretsen AL, Mulder PG, Oranje AP. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls? Pediatric allergy and immunology: official publication of the European Society of Pediatric Allergy and Immunology. 2009;20(1):59–66.

    Google Scholar 

  7. El-Batawy MM, Bosseila MA, Mashaly HM, Hafez VS. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis. J Dermatol Sci. 2009;54(2):76–87.

    CAS  PubMed  Google Scholar 

  8. Tennis P, Gelfand JM, Rothman KJ. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol. 2011;165(3):465–73.

    CAS  PubMed  Google Scholar 

  9. Thaci D, Salgo R. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies. Clin Dermatol. 2010;28(1):52–6.

    PubMed  Google Scholar 

  10. Berger TG, Duvic M, Van Voorhees AS, VanBeek MJ, Frieden IJ. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol. 2006;54(5):818–23.

    Google Scholar 

  11. Legendre L, Barnetche T, Mazereeuw-Hautier J, Meyer N, Murrell D, Paul C. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: a systematic review and meta-analysis. J Am Acad Dermatol. 2015;72(6):992–1002.

    PubMed  Google Scholar 

  12. Koo JY, Fleischer AB Jr, Abramovits W, Pariser DM, McCall CO, Horn TD, et al. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients. J Am Acad Dermatol. 2005;53(2 Suppl 2):S195–205.

    PubMed  Google Scholar 

  13. Devillers AC, Oranje AP. Efficacy and safety of ‘wet-wrap’ dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature. Br J Dermatol. 2006;154(4):579–85.

    CAS  PubMed  Google Scholar 

  14. Dabade TS, Davis DM, Wetter DA, Hand JL, McEvoy MT, Pittelkow MR, et al. Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic. J Am Acad Dermatol. 2012;67(1):100–6.

    CAS  PubMed  Google Scholar 

  15. Cooper CA, DeKlotz CMC. Warming up to the idea of wet wraps. Pediatr Dermatol. 2017;34(6):737–8.

    PubMed  Google Scholar 

  16. Sidbury R, Davis DM, Cohen DE, Cordoro KM, Berger TG, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2):327–49.

    Google Scholar 

  17. Astellas. Medication guide (tacrolimus). http://www.protopic.com/pdf/protopic_med_guide.pdf.

  18. Medicis. Prescribing information (pimecrolimus). http://elidel-us.com/files/Elidel_PI.pdf.

  19. Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol. 2000;142(1):52–8.

    CAS  PubMed  Google Scholar 

  20. Heller M, Shin HT, Orlow SJ, Schaffer JV. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. J Dermatol. 2007;157(1):127–32.

    CAS  Google Scholar 

  21. Chang YS, Lin MH, Lee JH, Lee PL, Dai YS, Chu KH, et al. Melatonin supplementation for children with atopic dermatitis and sleep disturbance: a randomized clinical trial. JAMA Pediatr. 2016;170(1):35–42.

    PubMed  Google Scholar 

  22. Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L, et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ (Clin Res ed). 2006;332(7538):385–93.

    CAS  Google Scholar 

  23. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123(5):e808–14.

    PubMed  Google Scholar 

  24. Darrow DH, Greene AK, Mancini AJ, Nopper AJ. Diagnosis and management of infantile hemangioma. Pediatrics. 2015;136(4):e1060–104.

    PubMed  Google Scholar 

  25. Jahnke MN. Vascular lesions. Pediatr Ann. 2016;45(8):e299–305.

    PubMed  Google Scholar 

  26. Luu M, Frieden IJ. Haemangioma: clinical course, complications and management. Br J Dermatol. 2013;169(1):20–30.

    CAS  PubMed  Google Scholar 

  27. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007;150(3):291–4.

    PubMed  Google Scholar 

  28. Maguiness SM, Hoffman WY, McCalmont TH, Frieden IJ. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol. 2010;146(11):1235–9.

    PubMed  Google Scholar 

  29. Chamlin SL, Haggstrom AN, Drolet BA, Baselga E, Frieden IJ, Garzon MC, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr. 2007;151(6):684–9, 9.e1.

    Google Scholar 

  30. Samuelov L, Kinori M, Rychlik K, Konanur M, Chamlin SL, Rahmani B, et al. Risk factors for ocular complications in periocular infantile hemangiomas. Pediatr Dermatol. 2018;35(4):458–62.

    PubMed  Google Scholar 

  31. Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution. J Pediatr. 1997;131(4):643–6.

    CAS  PubMed  Google Scholar 

  32. Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996;132(3):307–11.

    CAS  PubMed  Google Scholar 

  33. Siegel DH, Tefft KA, Kelly T, Johnson C, Metry D, Burrows P, et al. Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: a systematic review of the literature. Stroke. 2012;43(6):1672–4.

    PubMed  Google Scholar 

  34. Metry DW, Garzon MC, Drolet BA, Frommelt P, Haggstrom A, Hall J, et al. PHACE syndrome: current knowledge, future directions. Pediatr Dermatol. 2009;26(4):381–98.

    PubMed  Google Scholar 

  35. Iacobas I, Burrows PE, Frieden IJ, Liang MG, Mulliken JB, Mancini AJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr. 2010;157(5):795–801.e1-7.

    Google Scholar 

  36. Huang SA, Tu HM, Harney JW, Venihaki M, Butte AJ, Kozakewich HP, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. New Engl J Med. 2000;343(3):185–9.

    CAS  PubMed  Google Scholar 

  37. de Graaf M, Pasmans SG, van Drooge AM, Nievelstein RA, Gooskens RH, Raphael MF, et al. Associated anomalies and diagnostic approach in lumbosacral and perineal haemangiomas: case report and review of the literature. J Plast Reconstr Aesthet Surg JPRAS. 2013;66(1):e26–8.

    PubMed  Google Scholar 

  38. Khan M, Boyce A, Prieto-Merino D, Svensson A, Wedgeworth E, Flohr C. The role of topical timolol in the treatment of infantile hemangiomas: a systematic review and meta-analysis. Acta Dermato-Venereol. 2017;97(10):1167–71.

    CAS  Google Scholar 

  39. Blatt J, Morrell DS, Buck S, Zdanski C, Gold S, Stavas J, et al. Beta-blockers for infantile hemangiomas: a single-institution experience. Clin Pediatr. 2011;50(8):757–63.

    Google Scholar 

  40. Boos MD, Castelo-Soccio L. Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH). J Am Acad Dermatol. 2016;74(3):567–70.

    PubMed  Google Scholar 

  41. Kumar MG, Coughlin C, Bayliss SJ. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines. Pediatr Dermatol. 2015;32(2):171–9.

    PubMed  Google Scholar 

  42. Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128–40.

    PubMed  PubMed Central  Google Scholar 

  43. Chen MT, Yeong EK, Horng SY. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. J Pediatr Surg. 2000;35(3):420–3.

    CAS  PubMed  Google Scholar 

  44. Ceisler EJ, Santos L, Blei F. Periocular hemangiomas: what every physician should know. Pediatr Dermatol. 2004;21(1):1–9.

    PubMed  Google Scholar 

  45. Frieden IJ. Which hemangiomas to treat–and how? Arch Dermatol. 1997;133(12):1593–5.

    CAS  PubMed  Google Scholar 

  46. Stier MF, Glick SA, Hirsch RJ. Laser treatment of pediatric vascular lesions: port wine stains and hemangiomas. J Am Acad Dermatol. 2008;58(2):261–85.

    PubMed  Google Scholar 

  47. Morelli JG, Tan OT, Yohn JJ, Weston WL. Treatment of ulcerated hemangiomas infancy. Arch Pediatr Adolesc Med. 1994;148(10):1104–5.

    CAS  PubMed  Google Scholar 

  48. Wang JY, Ighani A, Ayala AP, Akita S, Lara-Corrales I, Alavi A. Medical, surgical, and wound care management of Ulcerated Infantile hemangiomas: a systematic review [Formula: see text]. J Cutan Med Surg. 2018;22(5):495–504.

    PubMed  Google Scholar 

  49. Kim HJ, Colombo M, Frieden IJ. Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol. 2001;44(6):962–72.

    CAS  PubMed  Google Scholar 

  50. Saint-Jean M, Leaute-Labreze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, et al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011;64(5):827–32.

    CAS  PubMed  Google Scholar 

  51. Tran AN, Koo JY. Risk of systemic toxicity with topical lidocaine/prilocaine: a review. J Drugs Dermatol JDD. 2014;13(9):1118–22.

    CAS  PubMed  Google Scholar 

  52. Berger EM, Orlow SJ, Patel RR, Schaffer JV. Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: the bump that rashes. Arch Dermatol. 2012;148(11):1257–64.

    CAS  PubMed  Google Scholar 

  53. Butala N, Siegfried E, Weissler A. Molluscum BOTE sign: a predictor of imminent resolution. Pediatrics. 2013;131(5):e1650–3.

    PubMed  Google Scholar 

  54. Coloe J, Morrell DS. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum. Pediatr Dermatol. 2009;26(4):405–8.

    PubMed  Google Scholar 

  55. Jahnke MN, Hwang S, Griffith JL, Shwayder T. Cantharidin for treatment of facial molluscum contagiosum: a retrospective review. J Am Acad Dermatol. 2018;78(1):198–200.

    PubMed  Google Scholar 

  56. Piggot C, Friedlander SF, Tom W. Poxvirus infections. In: Goldsmith LA, Katz SI, Gilchrest BA, et al. editors. Fitzpatrick’s dermatology in general medicine. 2: McGraw-Hill; 2012. p. 2402.

    Google Scholar 

  57. Hanna D, Hatami A, Powell J, Marcoux D, Maari C, Savard P, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol. 2006;23(6):574–9.

    PubMed  Google Scholar 

  58. Harel A, Kutz AM, Hadj-Rabia S, Mashiah J. To treat molluscum contagiosum or not-curettage: an effective well-accepted treatment modality. Pediatr Dermatol. 2016;33(6):640–5.

    PubMed  Google Scholar 

  59. Al-Mutairi N, Al-Doukhi A, Al-Farag S, Al-Haddad A. Comparative study on the efficacy, safety, and acceptability of imiquimod 5% cream versus cryotherapy for molluscum contagiosum in children. Pediatr Dermatol. 2010;27(4):388–94.

    PubMed  Google Scholar 

  60. Isaacs SN. Molluscum contagiosum. 27 July 2017.

    Google Scholar 

  61. Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52(9):2873–81.

    PubMed  Google Scholar 

  62. Harrington CI, Dunsmore IR. An investigation into the incidence of auto-immune disorders in patients with localized morphoea. Br J Dermatol. 1989;120(5):645–8.

    CAS  PubMed  Google Scholar 

  63. Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, et al. Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res. 2012;64(8):1175–85.

    CAS  Google Scholar 

  64. Uziel Y, Feldman BM, Krafchik BR, Yeung RS, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr. 2000;136(1):91–5.

    CAS  PubMed  Google Scholar 

  65. Torok KS, Arkachaisri T. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. J Rheumatol. 2012;39(2):286–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. Martini G, Ramanan AV, Falcini F, Girschick H, Goldsmith DP, Zulian F. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil. Rheumatology (Oxford, England). 2009;48(11):1410–3.

    Google Scholar 

  67. Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O’Neil KM. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J Rheumatol. 2010;37(1):175–81.

    PubMed  Google Scholar 

  68. Martini G, Campus S, Raffeiner B, Boscarol G, Meneghel A, Zulian F. Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases? Clin Exp Rheumatol. 2017;35 Suppl 106(4):211–3.

    Google Scholar 

  69. Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol. 2001;45(5):697–9.

    CAS  PubMed  Google Scholar 

  70. Kreuter A, Hyun J, Skrygan M, Sommer A, Bastian A, Altmeyer P, et al. Ultraviolet al-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma. Br J Dermatol. 2006;155(3):600–7.

    CAS  PubMed  Google Scholar 

  71. De Rie MA, Bos JD. Photochemotherapy for systemic and localized scleroderma. J Am Acad Dermatol. 2000;43(4):725–6.

    PubMed  Google Scholar 

  72. Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol. 1998;38(1):21–6.

    CAS  PubMed  Google Scholar 

  73. Sengezer M, Deveci M, Selmanpakoglu N. Repair of “coup de sabre,” a linear form of scleroderma. Ann Plast Surg. 1996;37(4):428–32.

    CAS  PubMed  Google Scholar 

  74. Lapiere JC, Aasi S, Cook B, Montalvo A. Successful correction of depressed scars of the forehead secondary to trauma and morphea en coup de sabre by en bloc autologous dermal fat graft. Dermatol Surg Off Publ Am Soc Dermatol Surg. 2000;26(8):793–7.

    CAS  Google Scholar 

  75. Palmero ML, Uziel Y, Laxer RM, Forrest CR, Pope E. En coup de sabre scleroderma and Parry-Romberg syndrome in adolescents: surgical options and patient-related outcomes. J Rheumatol. 2010;37(10):2174–9.

    PubMed  Google Scholar 

  76. Patrizi A, Costa AM, Fiorillo L, Neri I. Perianal streptococcal dermatitis associated with guttate psoriasis and/or balanoposthitis: a study of five cases. Pediatr Dermatol. 1994;11(2):168–71.

    CAS  PubMed  Google Scholar 

  77. Herbst RA, Hoch O, Kapp A, Weiss J. Guttate psoriasis triggered by perianal streptococcal dermatitis in a four-year-old boy. J Am Acad Dermatol. 2000;42(5 Pt 2):885–7.

    CAS  PubMed  Google Scholar 

  78. Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making Int J Soc Med Decis Making. 1981;1(3):239–46.

    CAS  Google Scholar 

  79. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291(13):1587–95.

    CAS  PubMed  Google Scholar 

  80. Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical practice guideline for the diagnosis and management of group a streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis Off Public Infect Dis Soc Am. 2012;55(10):1279–82.

    CAS  Google Scholar 

  81. Garritsen FM, Kraag DE, de Graaf M. Guttate psoriasis triggered by perianal streptococcal infection. Clin Exper Dermatol. 2017;42(5):536–8.

    CAS  Google Scholar 

  82. Kwa L, Kwa MC, Silverberg JI. Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States. J Am Acad Dermatol. 2017;77(6):1023–9.

    PubMed  PubMed Central  Google Scholar 

  83. Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schafer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633–6.

    CAS  PubMed  Google Scholar 

  84. Koebnick C, Black MH, Smith N, Der-Sarkissian JK, Porter AH, Jacobsen SJ, et al. The association of psoriasis and elevated blood lipids in overweight and obese children. J Pediatr. 2011;159(4):577–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Osier E, Wang AS, Tollefson MM, Cordoro KM, Daniels SR, Eichenfield A, et al. Pediatric psoriasis comorbidity screening guidelines. JAMA Dermatol. 2017;153(7):698–704.

    PubMed  PubMed Central  Google Scholar 

  86. van Geel MJ, Oostveen AM, Hoppenreijs EP, Hendriks JC, van de Kerkhof PC, de Jong EM, et al. Methotrexate in pediatric plaque-type psoriasis: long-term daily clinical practice results from the Child-CAPTURE registry. J Dermatol Treat. 2015;26(5):406–12.

    Google Scholar 

  87. Kaur I, Dogra S, De D, Kanwar AJ. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India. Pediatr Dermatol. 2008;25(2):184–8.

    PubMed  Google Scholar 

  88. Collin B, Vani A, Ogboli M, Moss C. Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exper Dermatol. 2009;34(3):295–8.

    CAS  Google Scholar 

  89. Pavlovsky M, Baum S, Shpiro D, Pavlovsky L, Pavlotsky F. Narrow band UVB: is it effective and safe for paediatric psoriasis and atopic dermatitis? J Eur Acad Dermatol Venereol JEADV. 2011;25(6):727–9.

    CAS  PubMed  Google Scholar 

  90. Zamberk P, Velazquez D, Campos M, Hernanz JM, Lazaro P. Paediatric psoriasis–narrowband UVB treatment. J Eur Acad Dermatol Venereol JEADV. 2010;24(4):415–9.

    CAS  PubMed  Google Scholar 

  91. Tan E, Lim D, Rademaker M. Narrowband UVB phototherapy in children: a New Zealand experience. Australas J Dermatol. 2010;51(4):268–73.

    PubMed  Google Scholar 

  92. van Geel MJ, Mul K, de Jager ME, van de Kerkhof PC, de Jong EM, Seyger MM. Systemic treatments in paediatric psoriasis: a systematic evidence-based update. J Eur Acad Dermatol Venereol JEADV. 2015;29(3):425–37.

    PubMed  Google Scholar 

  93. Di Lernia V, Stingeni L, Boccaletti V, Calzavara Pinton PG, Guarneri C, Belloni Fortina A, et al. Effectiveness and safety of cyclosporine in pediatric plaque psoriasis: a multicentric retrospective analysis. J Dermatol Treat. 2016;27(5):395–8.

    Google Scholar 

  94. Di Lernia V, Bonamonte D, Lasagni C, Belloni Fortina A, Cambiaghi S, Corazza M, et al. Effectiveness and safety of acitretin in children with plaque psoriasis: a multicenter retrospective analysis. Pediatr Dermatol. 2016;33(5):530–5.

    PubMed  Google Scholar 

  95. Charbit L, Mahe E, Phan A, Chiaverini C, Boralevi F, Bourrat E, et al. Systemic treatments in childhood psoriasis: a French multicentre study on 154 children. Br J Dermatol. 2016;174(5):1118–21.

    CAS  PubMed  Google Scholar 

  96. Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol. 2001;45(5):649–61; quiz 62-4.

    CAS  PubMed  Google Scholar 

  97. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol. 2003;49(2):171–82; quiz 83-6.

    Google Scholar 

  98. Garber C, Creighton-Smith M, Sorensen EP, Dumont N, Gottlieb AB. Systemic treatment of recalcitrant pediatric psoriasis: a case series and literature review. J Drugs Dermatol JDD. 2015;14(8):881–6.

    CAS  PubMed  Google Scholar 

  99. Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, et al. Etanercept treatment for children and adolescents with plaque psoriasis. New Engl J Med. 2008;358(3):241–51.

    CAS  PubMed  Google Scholar 

  100. Paller AS, Siegfried EC, Eichenfield LF, Pariser D, Langley RG, Creamer K, et al. Long-term etanercept in pediatric patients with plaque psoriasis. J Am Acad Dermatol. 2010;63(5):762–8.

    CAS  PubMed  Google Scholar 

  101. Papp K, Thaci D, Marcoux D, Weibel L, Unnebrink K, Williams D. Efficacy and safety of adalimumab versus methotrexate treatment in pediatric patients with severe chronic plaque psoriasis: Results from the 16-week randomized, double-blind period of a phase 3 study. In: 4th World Psoriasis and Psoriatic Arthritis Conference on Psoriasis 2015. J Investig Dermatol.

    Google Scholar 

  102. Papp K, Thaci D, Marcoux D, Weibel L, Philipp S, Ghislain PD, et al. Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial. Lancet (London, England). 2017;390(10089):40–9.

    CAS  Google Scholar 

  103. FDA. Full prescribing information: adalimumab. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125057s232lbl.pdf.

  104. Kivelevitch D, Menter A. Adalimumab in paediatric psoriasis. Lancet (London, England). 2017;390(10089):5–6.

    Google Scholar 

  105. Johnson J. Janssen announces U.S. FDA approval of Stelara (Ustekinumab) for the treatment of adolescents with moderate to severe plaque psoriasis Horsham, PA: Johnson & Johnson; 2017. https://www.jnj.com/media-center/press-releases/janssen-announces-us-fda-approval-of-stelara-ustekinumab-for-the-treatment-of-adolescents-with-moderate-to-severe-plaque-psoriasis.

  106. McMillin BD, Maddern BR, Graham WR. A role for tonsillectomy in the treatment of psoriasis? Ear Nose Throat J. 1999;78(3):155–8.

    CAS  PubMed  Google Scholar 

  107. Saita B, Ishii Y, Ogata K, Kikuchi I, Inoue S, Naritomi K. Two sisters with guttate psoriasis responsive to tonsillectomy: case reports with HLA studies. J Dermatol. 1979;6(3):185–9.

    CAS  PubMed  Google Scholar 

  108. Hone SW, Donnelly MJ, Powell F, Blayney AW. Clearance of recalcitrant psoriasis after tonsillectomy. Clin Otolaryngol Allied Sci. 1996;21(6):546–7.

    CAS  PubMed  Google Scholar 

  109. Wu W, Debbaneh M, Moslehi H, Koo J, Liao W. Tonsillectomy as a treatment for psoriasis: a review. J Dermatol Treat. 2014;25(6):482–6.

    Google Scholar 

  110. Thorleifsdottir RH, Sigurdardottir SL, Sigurgeirsson B, Olafsson JH, Sigurdsson MI, Petersen H, et al. Improvement of psoriasis after tonsillectomy is associated with a decrease in the frequency of circulating T cells that recognize streptococcal determinants and homologous skin determinants. J Immunol (Baltimore, Md: 1950). 2012;188(10):5160–5.

    Google Scholar 

  111. Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Phys. 2014;90(10):702–10.

    Google Scholar 

  112. John AM, Schwartz RA, Janniger CK. The kerion: an angry tinea capitis. Int J Dermatol. 2018;57(1):3–9.

    PubMed  Google Scholar 

  113. Bennassar A, Grimalt R. Management of tinea capitis in childhood. Clin Cosmet Investig Dermatol. 2010;3:89–98.

    CAS  PubMed  PubMed Central  Google Scholar 

  114. Friedlander SF, Chan YC, Chan YH, Eichenfield LF. Onychomycosis does not always require systemic treatment for cure: a trial using topical therapy. Pediatr Dermatol. 2013;30(3):316–22.

    PubMed  Google Scholar 

  115. Hashimoto K, Fujiwara K, Punwaney J, DiGregorio F, Bostrom P, el-Hoshy K, et al. Post-scabetic nodules: a lymphohistiocytic reaction rich in indeterminate cells. J Dermatol. 2000;27(3):181–94.

    CAS  PubMed  Google Scholar 

  116. Wali GN, Felton SJ, McPherson T. Management of naevus sebaceous: a national survey of UK dermatologists and plastic surgeons. Clin Exp Dermatol. 2018;43(5):589–91.

    CAS  PubMed  Google Scholar 

  117. Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696–712.

    CAS  PubMed  Google Scholar 

  118. Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. The Cochrane database of systematic reviews. 2012;(9):Cd001781.

    Google Scholar 

  119. Field S, Irvine AD, Kirby B. The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients. Br J Dermatol. 2009;160(1):223–4.

    CAS  PubMed  Google Scholar 

  120. Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005;141(5):589–94.

    PubMed  Google Scholar 

  121. Herschthal J, McLeod MP, Zaiac M. Management of ungual warts. Dermatol Ther. 2012;25(6):545–50.

    PubMed  Google Scholar 

  122. Iscimen A, Aydemir EH, Goksugur N, Engin B. Intralesional 5-fluorouracil, lidocaine and epinephrine mixture for the treatment of verrucae: a prospective placebo-controlled, single-blind randomized study. J Eur Acad Dermatol Venereol JEADV. 2004;18(4):455–8.

    CAS  PubMed  Google Scholar 

  123. Pezeshkpoor F, Banihashemi M, Yazdanpanah MJ, Yousefzadeh H, Sharghi M, Hoseinzadeh H. Comparative study of topical 80% trichloroacetic acid with 35% trichloroacetic acid in the treatment of the common wart. J Drugs Dermatol JDD. 2012;11(11):e66–9.

    PubMed  Google Scholar 

  124. Sparreboom EE, Luijks HG, Luiting-Welkenhuyzen HA, Willems PW, Groeneveld CP, Bovenschen HJ. Pulsed-dye laser treatment for recalcitrant viral warts: a retrospective case series of 227 patients. Br J Dermatol. 2014;171(5):1270–3.

    CAS  PubMed  Google Scholar 

  125. Broganelli P, Chiaretta A, Fragnelli B, Bernengo MG. Intralesional cidofovir for the treatment of multiple and recalcitrant cutaneous viral warts. Dermatol Ther. 2012;25(5):468–71.

    PubMed  Google Scholar 

  126. Blouin MM, Cloutier R, Noel R. Intralesional cidofovir in the treatment of cutaneous warts in a renal transplant patient. J Cutan Med Surg. 2012;16(6):462–4.

    PubMed  Google Scholar 

  127. Orlow SJ, Paller A. Cimetidine therapy for multiple viral warts in children. J Am Acad Dermatol. 1993;28(5 Pt 1):794–6.

    CAS  PubMed  Google Scholar 

  128. Yilmaz E, Alpsoy E, Basaran E. Cimetidine therapy for warts: a placebo-controlled, double-blind study. J Am Acad Dermatol. 1996;34(6):1005–7.

    CAS  PubMed  Google Scholar 

  129. Lee SH, Rose B, Thompson CH, Cossart Y. Plantar warts of defined aetiology in adults and unresponsiveness to low dose cimetidine. Australas J Dermatol. 2001;42(3):220–1.

    CAS  PubMed  Google Scholar 

  130. Rogers CJ, Gibney MD, Siegfried EC, Harrison BR, Glaser DA. Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol. 1999;41(1):123–7.

    CAS  PubMed  Google Scholar 

  131. Simone CD, Capizzi R, Carbone A, Fossati B, Valenzano F, Amerio P. Use of acitretin in a case of giant common warts in an HIV-infected patient. Eur J Dermatol EJD. 2008;18(3):346–7.

    PubMed  Google Scholar 

  132. Stefani M, Bottino G, Fontenelle E, Azulay DR. Efficacy comparison between cimetidine and zinc sulphate in the treatment of multiple and recalcitrant warts. Anais Brasileiros Dermatol. 2009;84(1):23–9.

    Google Scholar 

  133. Daniel BS, Murrell DF. Complete resolution of chronic multiple verruca vulgaris treated with quadrivalent human papillomavirus vaccine. JAMA Dermatol. 2013;149(3):370–2.

    PubMed  Google Scholar 

  134. Venugopal SS, Murrell DF. Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol. 2010;146(5):475–7.

    PubMed  Google Scholar 

  135. Abeck D, Folster-Holst R. Quadrivalent human papillomavirus vaccination: a promising treatment for recalcitrant cutaneous warts in children. Acta Dermato-Venereol. 2015;95(8):1017–9.

    CAS  Google Scholar 

  136. Sloan K, Haberman H, Lynde CW. Carbon dioxide laser-treatment of resistant verrucae vulgaris: retrospective analysis. J Cutan Med Surg. 1998;2(23):142–5.

    CAS  PubMed  Google Scholar 

  137. Schroeter CA, Kaas L, Waterval JJ, Bos PM, Neumann HA. Successful treatment of periungual warts using photodynamic therapy: a pilot study. J Eur Acad Dermatol Venereol JEADV. 2007;21(9):1170–4.

    CAS  PubMed  Google Scholar 

  138. Salem A, Nofal A, Hosny D. Treatment of common and plane warts in children with topical viable Bacillus Calmette-Guerin. Pediatr Dermatol. 2013;30(1):60–3.

    PubMed  Google Scholar 

  139. Chadha A, Jahnke M. Common neonatal rashes. Pediatr Ann. 2019;48(1):e16–22.

    PubMed  Google Scholar 

  140. Elish D, Silverberg NB. Infantile seborrheic dermatitis. Cutis. 2006;77(5):297–300.

    PubMed  Google Scholar 

  141. Al Rashed A, Al Shehri M, Kaliyadan F. Acrodermatitis enteropathica in a pair of twins. J Dermatol Case Rep. 2016;10(4):65–7.

    PubMed  PubMed Central  Google Scholar 

  142. Maverakis E, Fung MA, Lynch PJ, Draznin M, Michael DJ, Ruben B, et al. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol. 2007;56(1):116–24.

    PubMed  Google Scholar 

  143. Neldner KH, Hambidge KM. Zinc therapy of acrodermatitis enteropathica. New Engl J Med. 1975;292(17):879–82.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Henry Ford Health System, 3031 West Grand Blvd, Suite 800, Detroit, MI, 48202, USA

    Allison Zarbo, Marla Jahnke & Tor Shwayder

Authors
  1. Allison Zarbo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marla Jahnke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tor Shwayder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tor Shwayder .

Editor information

Editors and Affiliations

  1. Department of Dermatology, Henry Ford Health System, Detroit, MI, USA

    Henry W. Lim

  2. Department of Dermatology, Henry Ford Health System, Detroit, MI, USA

    Laurie L. Kohen

  3. Department of Dermatology, Henry Ford Health System, Detroit, MI, USA

    Samantha L. Schneider

  4. Department of Dermatology, Henry Ford Health System, Detroit, MI, USA

    Danielle Yeager

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zarbo, A., Jahnke, M., Shwayder, T. (2020). Pediatrics. In: Lim, H., Kohen, L., Schneider, S., Yeager, D. (eds) Practical Guide to Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-18015-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18015-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18014-0

  • Online ISBN: 978-3-030-18015-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation